This suppression of BID and BIM complements the Tax-driven upregulation and stabilization of anti-apoptotic BCL-2 family (such as BCL-xL, Bfl-1, and MCL-1), collectively ensuring persistence of infected cells and contributing to leukemogenesis in ATLL. The gene discussed is BCL2A1; the disease is adult T-cell leukemia/lymphoma.